Cynata Therapeutics Ltd
CYP
Company Profile
Business description
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus. There are currently three active clinical trials taking place using Cymerus technology which are attempting to treat osteoarthritis, respiratory distress, and diabetic foot ulcers.
Contact
100 Cubitt Street
Level 3
Cremorne VIC 3121
AUST: +61 370676940
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
2
Stocks News & Analysis
stocks
Any benefit from acquisition of ASX listed company’s business units?
Private equity strikes again but it is difficult to conclude if shareholders are winners from the deal.
stocks
3 ASX shares to avoid
These shares have surged in price in the last year but are significantly overvalued according to our analysts.
stocks
How to find companies that can grow forever
If you want to find companies with a long growth runway, try looking for these seven attributes.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,006.20 | 70.50 | -0.87% |
| CAC 40 | 8,131.41 | 55.73 | 0.69% |
| DAX 40 | 18,498.38 | 68.33 | 0.37% |
| Dow JONES (US) | 39,056.39 | 172.13 | 0.44% |
| FTSE 100 | 8,354.05 | 40.38 | 0.49% |
| HKSE | 18,437.06 | 123.20 | 0.67% |
| NASDAQ | 16,302.76 | 29.80 | -0.18% |
| Nikkei 225 | 38,392.10 | 189.73 | 0.50% |
| NZX 50 Index | 11,711.07 | 71.82 | -0.61% |
| S&P 500 | 5,187.67 | 0.03 | -0.00% |
| S&P/ASX 200 | 7,733.20 | 71.30 | -0.91% |
| SSE Composite Index | 3,147.43 | 18.95 | 0.61% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Imugene Ltd IMU | 0.07 | 0.00 | -5.33% |
| Sayona Mining Ltd SYA | 0.04 | 0.00 | 2.70% |
| Strike Energy Ltd STX | 0.24 | 0.02 | 6.82% |
| Westpac Banking Corp WBC | 26.35 | 1.54 | -5.52% |
| Pilbara Minerals Ltd PLS | 4.12 | 0.07 | -1.56% |
| Mesoblast Ltd MSB | 1.11 | 0.03 | -2.21% |
| Carnarvon Energy Ltd CVN | 0.20 | 0.01 | 2.56% |
| Botanix Pharmaceuticals Ltd BOT | 0.28 | 0.01 | -3.45% |
| Cleanaway Waste Management Ltd CWY | 2.69 | 0.03 | -1.10% |
| Telstra Group Ltd TLS | 3.64 | 0.02 | -0.41% |